• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SD大鼠多阶段进展为非酒精性脂肪性肝炎并继发肝纤维化的综合研究

Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.

作者信息

Wang Lulu, Wu Susu, Cai Minxuan, Ma Ji, Li Shengcun, Li Maoru, Xu Yan, Wei Lixin, Shang Jing

机构信息

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China.

出版信息

Int J Mol Sci. 2017 Aug 18;18(8):1681. doi: 10.3390/ijms18081681.

DOI:10.3390/ijms18081681
PMID:28820447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5578071/
Abstract

Because of the absence of the time course of histological nonalcoholic fatty hepatitis with subsequent fibrotic progression, the effective approaches available for controlling the onset and progression of non-alcoholic steatohepatitis (NASH) remain limited. Therefore, we detected the serum and liver tissue related lipid metabolism disorder, liver pathology and relative molecular makers alteration dynamically in a high fat-sucrose diet during different time points. High fat-sucrose diet significantly increased the serum lipid level on day 10. The excess lipid accumulation in liver was referred to as simple steatosis after the feeding of a high fat-sucrose diet for 20 days. The high fat-sucrose diet induced a hepatic inflammation response on day 30. Similarly, hepatic fibrosis was also initiated on day 30 and gradually formed from the 30th to the 50th day. Oxidative stress may be related with the process from NASH to liver fibrosis. Insulin resistance was involved in the progression from hepatic steatosis to NASH with hepatic fibrosis from the 20th to the 50th day. In conclusion, we established a high fat-sucrose diet induced nonalcoholic fatty hepatitis with liver fibrosis rat model, which presented the time course of histological nonalcoholic steatohepatitis and the initiation and progression change of characteristic molecular makers in the process from steatosis to hepatic fibrosis.

摘要

由于缺乏组织学上非酒精性脂肪性肝炎及其随后纤维化进展的时间进程,目前可用于控制非酒精性脂肪性肝炎(NASH)发病和进展的有效方法仍然有限。因此,我们在高脂高糖饮食的不同时间点动态检测血清和肝组织相关脂质代谢紊乱、肝脏病理学以及相关分子标志物的变化。高脂高糖饮食在第10天时显著提高了血清脂质水平。在高脂高糖饮食喂养20天后,肝脏中过量的脂质积累被称为单纯性脂肪变性。高脂高糖饮食在第30天时诱导了肝脏炎症反应。同样,肝纤维化也在第30天开始,并在第30天至第50天逐渐形成。氧化应激可能与从NASH到肝纤维化的过程有关。从第20天到第50天,胰岛素抵抗参与了从肝脂肪变性到NASH伴肝纤维化的进展过程。总之,我们建立了一种高脂高糖饮食诱导的非酒精性脂肪性肝炎伴肝纤维化大鼠模型,该模型呈现了组织学非酒精性脂肪性肝炎的时间进程以及从脂肪变性到肝纤维化过程中特征性分子标志物的起始和进展变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/23846f9268b8/ijms-18-01681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/4e5032c7f4c3/ijms-18-01681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/4b8babbeb9bd/ijms-18-01681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/b4f9867df113/ijms-18-01681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/90a3761d4e96/ijms-18-01681-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/c2fe5079d8f9/ijms-18-01681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/23846f9268b8/ijms-18-01681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/4e5032c7f4c3/ijms-18-01681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/4b8babbeb9bd/ijms-18-01681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/b4f9867df113/ijms-18-01681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/90a3761d4e96/ijms-18-01681-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/c2fe5079d8f9/ijms-18-01681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1606/5578071/23846f9268b8/ijms-18-01681-g006.jpg

相似文献

1
Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.SD大鼠多阶段进展为非酒精性脂肪性肝炎并继发肝纤维化的综合研究
Int J Mol Sci. 2017 Aug 18;18(8):1681. doi: 10.3390/ijms18081681.
2
Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.高脂高胆固醇饮食喂养的斯普拉格-道利大鼠非酒精性脂肪性肝炎的年龄相关性改变
J Nutr Sci Vitaminol (Tokyo). 2019;65(4):349-356. doi: 10.3177/jnsv.65.349.
3
Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.营养基因组学分析表明,在非酒精性脂肪性肝病的成熟大鼠模型中,铜缺乏和膳食蔗糖会上调炎症、纤维化和脂肪生成途径。
J Nutr Biochem. 2015 Oct;26(10):996-1006. doi: 10.1016/j.jnutbio.2015.04.009. Epub 2015 May 15.
4
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
5
Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.饮食性非酒精性脂肪性肝炎小鼠模型中代谢、炎症和纤维化变化的综合特征。
J Nutr Biochem. 2020 Nov;85:108463. doi: 10.1016/j.jnutbio.2020.108463. Epub 2020 Jul 10.
6
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.利拉鲁肽、奥贝胆酸和 Elafibranor 在经活检证实的非酒精性脂肪性肝炎肥胖小鼠模型中的代谢和肝脏作用。
World J Gastroenterol. 2018 Jan 14;24(2):179-194. doi: 10.3748/wjg.v24.i2.179.
7
Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.在豚鼠模型中,非酒精性脂肪性肝炎的分子驱动因素在从轻度到晚期纤维化进展中持续存在。
Mol Genet Genomics. 2019 Jun;294(3):649-661. doi: 10.1007/s00438-019-01537-z. Epub 2019 Feb 13.
8
Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.有氧运动训练用于治疗非酒精性脂肪性肝病相关纤维化
J Physiol. 2016 Sep 15;594(18):5271-84. doi: 10.1113/JP272235. Epub 2016 May 27.
9
Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.肠道固醇调节元件结合蛋白2的过度激活会促进饮食诱导的非酒精性脂肪性肝炎。
Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G376-G385. doi: 10.1152/ajpgi.00174.2017. Epub 2017 Aug 3.
10
Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.支链氨基酸可减轻胆碱缺乏高脂饮食诱导的非酒精性脂肪性肝炎(NASH)小鼠的肝脂肪变性和肝损伤。
Metabolism. 2017 Apr;69:177-187. doi: 10.1016/j.metabol.2016.12.013. Epub 2017 Jan 4.

引用本文的文献

1
Gut-Derived Serotonin Contributes to the Progression of Non-Alcoholic Steatohepatitis the Liver HTR2A/PPARγ2 Pathway.肠道来源的血清素通过肝脏HTR2A/PPARγ2途径促进非酒精性脂肪性肝炎的进展。
Front Pharmacol. 2020 May 14;11:553. doi: 10.3389/fphar.2020.00553. eCollection 2020.
2
Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development.代谢组学解析槲皮素在非酒精性脂肪肝病发展中的作用和机制。
Int J Mol Sci. 2019 Mar 11;20(5):1220. doi: 10.3390/ijms20051220.

本文引用的文献

1
Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress.小檗碱通过减轻内质网应激来预防肝脂肪变性进展为脂肪性肝炎和肝纤维化。
Sci Rep. 2016 Feb 9;6:20848. doi: 10.1038/srep20848.
2
Emerging therapeutic targets for the treatment of hepatic fibrosis.治疗肝纤维化的新兴治疗靶点
Drug Discov Today. 2016 Feb;21(2):369-75. doi: 10.1016/j.drudis.2015.10.015. Epub 2015 Oct 30.
3
Nonalcoholic fatty liver disease - current status and future directions.非酒精性脂肪性肝病——现状与未来方向
J Dig Dis. 2015 Oct;16(10):541-57. doi: 10.1111/1751-2980.12291.
4
Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis.非酒精性脂肪性肝炎及随后纤维化小鼠模型中肝脏脂质谱的特征分析
Sci Rep. 2015 Aug 20;5:12466. doi: 10.1038/srep12466.
5
Hepatic Steatosis as a Marker of Metabolic Dysfunction.肝脂肪变性作为代谢功能障碍的标志物
Nutrients. 2015 Jun 19;7(6):4995-5019. doi: 10.3390/nu7064995.
6
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.新型过氧化物酶体增殖物激活受体激动剂:治疗动脉粥样硬化性血脂异常和非酒精性脂肪性肝病的潜在药物。
Expert Opin Pharmacother. 2014 Mar;15(4):493-503. doi: 10.1517/14656566.2014.876992. Epub 2014 Jan 16.
7
Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death.脂质激活的炎症激活的枯否细胞通过激活诱导的细胞死亡诱导肝 NKT 细胞缺失。
PLoS One. 2013 Dec 3;8(12):e81949. doi: 10.1371/journal.pone.0081949. eCollection 2013.
8
A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance.一种具有显著胰岛素抵抗的非酒精性脂肪性肝炎新型小鼠模型。
Lab Invest. 2013 Dec;93(12):1313-22. doi: 10.1038/labinvest.2013.123. Epub 2013 Oct 21.
9
NAFLD, NASH and liver cancer.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝癌。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65. doi: 10.1038/nrgastro.2013.183. Epub 2013 Oct 1.
10
Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.固醇调节元件结合蛋白-1c 多态性对非酒精性脂肪性肝病的发生率及肝脏疾病严重程度和糖脂代谢紊乱的影响。
Am J Clin Nutr. 2013 Oct;98(4):895-906. doi: 10.3945/ajcn.113.063792. Epub 2013 Aug 28.